Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor agents from Pfizer inhibit tyrosine kinases

Feb. 8, 2002

Preparation and use of steroids for androgen- and estrogen-mediated diseases reported by Aventis

Feb. 8, 2002

CVS-3983: a promising lead inhibitor of the antitumor drug target matriptase

Feb. 8, 2002

CT-2106 cleared to enter phase I clinical testing

Feb. 7, 2002

Servier scientists prepare novel podophyllotoxin derivatives for cancer Rx

Feb. 6, 2002

Initiation of phase I clinical trial of XR-11576 in treatment of solid tumors

Feb. 6, 2002

Aromatic alphavbeta3 and/or alphavbeta5 integrin receptor antagonists disclosed by Pharmacia

Feb. 5, 2002

Corixa designs isoleucine-containing peptide prodrugs of antitumor agents

Feb. 5, 2002

Tricyclic compounds that inhibit MRP-1 are useful as oncolytics

Feb. 5, 2002

Gleevec approved for gastrointestinal stromal tumors

Feb. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...